Consumer interest in mullein-based respiratory supplements is accelerating, with Betterbrand citing surging demand for its BetterLungs finished formulations as shoppers increasingly seek botanical alternatives to conventional respiratory support products.
Mullein (Verbascum thapsus) has a long history in traditional herbal medicine as a respiratory aid, with modern interest focusing on its saponin and flavonoid content, which are believed to support mucus clearance and bronchial comfort. Betterbrand positions its BetterLungs line as clinically studied, though the breadth and design of that evidence — dose, endpoints, and whether trials are double-blind and placebo-controlled — was not detailed in the company's announcement. Operators evaluating the ingredient for finished formulation should request full dossier documentation, including standardized extract specifications and any structure-function claim substantiation on file.
Category Context
Respiratory health has emerged as one of the fastest-growing subcategories within the broader immune and wellness supplement market, a trend that accelerated sharply in the early 2020s and has shown sustained consumer pull. Botanicals including elderberry, echinacea, and andrographis have dominated retail shelf sets, but mullein is increasingly appearing in premium single-ingredient capsules, tinctures, and combination formulas targeting lung function and airway comfort. The ingredient's relatively low cost of goods, existing GRAS-adjacent safety profile in food use, and strong search-driven consumer awareness make it attractive for brand formulators and white-label co-manufacturing partners alike.
For brands monitoring the adaptogens and botanicals space, mullein's trajectory mirrors earlier demand curves seen with ashwagandha and reishi — a surge in direct-to-consumer channels preceding broader mass and natural grocery distribution. Betterbrand's move to publicly highlight the ingredient trend suggests the company is positioning BetterLungs as a category-defining SKU rather than a niche offering, a strategy with implications for shelf placement negotiations and retail buyer conversations heading into 2027 planning cycles.
Operator Takeaways
For product developers and brand managers active in the respiratory and immune health segment, mullein's rise warrants ingredient sourcing diligence. Key considerations include country of origin, standardization parameters (typically expressed as a percentage of saponins or specific marker compounds), and allergen cross-reactivity documentation. Betterbrand's public emphasis on clinical study differentiation also signals that efficacy substantiation is becoming a competitive threshold in this category — a dynamic that will likely raise the bar for structure-function claims across the mullein market as retailer scrutiny of supplement efficacy increases.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
